NEXEL Co., Ltd.
- Biotech or pharma, therapeutic R&D
NEXEL is a biotech company founded in 2012, specializing in human induced pluripotent stem cell (hiPSC) technology. Leveraging our proprietary hiPSC differentiation platform, we have commercialized functional cell models—including 2D monolayers and 3D organoids—that can be used for drug screening and evaluation in the drug development process.
NEXEL is open to potential collaborations for the development of New Approach Methodologies (NAMs) in drug development, utilizing our hiPSC-based products and services.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}